Having looked a bit more closely, I think these are really good results. I agree with every point you make, no point in my repeating them.
At a price of 49, I put the forward P/E ratio at around 32. That is demanding, and I can see the logic in your switch to IGG. I won't follow your example, because one of my rules is never touch financials, so I will continue to hold despite being well over-weight. I don't think the rating is excessive for the business.
I have a theory that low staff turnover correlates well with business success - unfortunately that is something we can usually only guess at from the Annual Report.
The results are very good.
This is simply some profit taking.
I've bought in on the expectation that the share price will recover very soon.
As with others I've been invested a long time with an excellent return, even without taking the dividends into account.
" or is there some underlying reason that is not obvious?"
There could be, but I doubt it very much - RSW seem pretty up front in their reporting.
I think the drop is just what you can expect on anything that reports anything these days, good bad or indifferent.
These were certainly not indifferent results, they were good results, that's all we can really ask for.
I'm hoping long term that healthcare, AM and Spectroscopy wil be much bigger shares of the business and profitable ones as well.
Games -- happy to keep as 3% of my wad, or a bit less today I guess lol !!
What's also nice is the Heathcare business is growing steadily and reduced loss from £6M to £1.9M and I expect this time next year it'll start to show a profit.
He's handed the CEO role to the Group Sales Director, which probably makes sense and he can now oversee the ship while he gets established.
EPS grew from 41p to 73p and the dividend is up, interim, from 12.5p to 14p (12%)
Increased R&D spend which should be encouraging.
Also the US grew 26% which was the concerning weaker area last year -- so maybe Trump is having an effect.
With all the money repatriated to the US and at long last a sensible corporation tax rate, I expect this will continue to be the case.
The growth in the Additive Manufacturing Products looks really encouraging, and the Raman Spectroscopy business is really great to see -- there is so much opportunity for spectroscopy -- if you look on their web site they have made a little unit for assessing the constituent materials in tablets.
I could see them installing these at airports etc. http://www.renishaw.com/en/raman-spectroscopy--6150
The cash is growing nicely, derisking the operation somewhat -- it's now £69M compared to £14M last year. No debt, but the number of employees has risen to ove 4500 now, so operational gearing is there to see.
The outlook statement seems pretty confident.
I top sliced yesterday taking this down from 3.3% of my wad to 2.9% and the stock dropped 10%, the action was to allow me to invest more in IGG in the same account.
What I cant work out is this. The share price has risen pretty steadily for the last year. How did those buyers buy with such confidence? The only explanation that makes sense is that they knew that profits and sales would go up.
Now it might have been due to the Brexit effect, with the fall in the value of the pound going straight through to profit bottom line. But the foreign currency information was pretty much known immediately after the fall in the pound after Brexit and most of the share price rise subsequent to sterling's fall. Today excepted, the share price has risen at a steep but constant rate even during recent times when the pound has been rising against the dollar. Are the buyers party to information that the rest of us are not, or am I missing a good source of open information?
If the results are good, the analcysts can still potentially pick holes in it and force the stock price down temporarily -- although I'm not sure I'm comfortable buying back that slice again anyway at these levels. The additive manufacturing/robotic arms are still a small % of the biz and they have increased their loss so far last year compared to the year before.
I remain to be surprised, but I'm assuming both these new divsions have a long way to go timewise before, if, they become a healthy enough share of the business.
In the meantime let's pray that a manufacturing downturn doesn't happen anytime soon or the 75% which is the metrology biz will get a bit of a clobbering again.
Nice that they have a bigger cash balance though as of last time increasing it to £56M -- no debt. No debt is great but it doesn't mean no risk, as the operational gearing is high at Renishaw with all those new mouths to feed. They added 244 new employees. many in sales and delivery of the healthcare proposition.
That takes them up to 4530 employed for a revenue per head of just under £132K and a post tax profit per head of £29.9K.
Like Games, I am a bit puzzled. The results next Thursday should be good, but that was priced in at 45, let alone 57. And the currency tailwind is now a headwind. So what is happening? Only four more days to find out.
I put it down to a thin market, a shortage of quality businesses for investment - there are more Carillions out there - and the possibility of a pleasant surprise from AM. And, after all, this is a very cyclical business selling into a global upturn. So I will continue to work hard at just standing there.
Too right, nettle! I started buying these in 2011, first entry was at 848, since when I have been in and out top slicing here and there, but holding on for now, and showing an overall gain of 'only' 275% plus dividends - not to be sneezed at, but how daft of me not simply to have held and held for the long haul!
It's unlikely to be a bid, as the old boys hold ~52% between them, so they would, effectively, have to sell their shares for any bid to succeed. Of the other 10 top investors, only Baillie Gifford, at 5.3%, has over 5%, and that hasn't changed since last June, nor has Blackrock's 3.1%.
If the price hits £65, entry to the FTSE 100 beckons (currently we're 111th, up over 60 places yoy).
I assume next week's figures will be spectacular, and could do with a bump in the divi (under 1% at current prices). If they aren't, then probably we'll go tumbling back down to under £50 or less (consensus broker forecast has a median target of £42.50).
I've been thinking about top-slicing since before £30. This time, if it does hit £60 next week, I really will take 10% off the table, lowering my average book cost from £20 to £14 (but fortunately with no CGT implications, as they're all safely tucked up in my ISA).
"I don't think RSW make anything that goes in an iphone."
True, RSW doesn't make anything that goes into anything per se.
They are a tools supplier and measurement company principally.
Even when they move into Additive Manufacturing it's most likely to be providing the kit and training the end customer..
It's interesting how RSW has managed to scale so much with that model -- they certainly could have the capability to outright manufacture things but that sets them against their customers and it's also a whole different financial ball game and infrastructure set up.
Games -- let's hope there isn't a downturn in manufacturing, or RSW will easily halve in price.
Well, they regularly get contracted by Apple to make things to put in iPhones, does that count?"
I don't think RSW make anything that goes in an iphone.
Further investigation reveals that an analyst had discovered that Japanese machine tool orders had increased some 28% where RSW probes are extensively used and a major market for their machine tools is China where factories machine the iphone8 casing.
An Apple promotional video showed an RSW probe being used when a casing was being machined so this analyst puts two and two together and makes twelve, concluding that due to upsides in the consumer electronic market that the Japanese are going to sell more machine tools to China with RSW probes that will machine Apple iphone8 casings!!
The analyst reckoned earnings increases of between 10 and 30% for RSW as a result.
Current year on year growth in that market is about 28% and based on the latest accounts, metrology sales to Asia would need to increase by a further 67% to achieve a 30% increase in RSW total revenue ie: about £160m and that's an awful lot of probes.
I concur with the first two reasons but am unable to see how they could benefit from "upsides in consumer electronics" considering they have absolutely no business in that market? -asks BertieB
Well, they regularly get contracted by Apple to make things to put in iPhones, does that count?
UBS say that SP's in RSW may have " benefited from improved general industrial demand, auto production growth and upside in consumer electronics"
I concur with the first two reasons but am unable to see how they could benefit from "upsides in consumer electronics" considering they have absolutely no business in that market?
UBS are one of many who have been predicting RSW doom and gloom for some time. It might be something to do with bankers inability to predict anything economic correctly since 2008 when they messed up big time.
RSW are overpriced and the prudent amongst us may be tempted to sell. Fundamentalists on the other hand who are invested for the longer term should continue to hold IMO.
Tom, this has been on a fantastic run for a few years, now could be the opportune time to pocket some of the profits we have enjoyed on this journey. Good luck to all who have a holding in this company, I'm sure there is more come.
This is by far my best performing share this year in a portfolio of about 13 or so. I like the company too and still think it is good value but am keeping a sharp eye out for any significant drop in the share price.
According to today's FT (page 22) UBS have downgraded RSW with a target price of £45.35, arguing that it is expensive at a 70% premium to its sector. We have had these downgrades from brokers before, but at the moment, I am comfortable with the shares, though I will look out for developments next week.
Interesting to look back to my post 06/10 when the share price had dipped to 4,670.
I said then: "IMHO this is a definite buying opportunity which LKH may regret if he ignores it.
The broker downgrade to which Blanketstacker refers was Deutsche Bank. In August they advised sell with a target of 3180 and now they have an increased target of 3630 and are still saying sell.
If this is really the reason for the sudden drop then I think investors should doubt the advice of a bank who consistently is unable to get its own affairs in order can be trusted to predict others.
This share is expensive at the moment as LKH says but it will seem cheap in a few years. Day traders can forget it but it is a share for the long term."
Well it looks like I was wrong about Day traders ignoring the stock but as I write it is 5,550 so a nice little profit of nearly 19% if you took my advice and saw the drop as a buying opportunity. Looks like Deutsche Bank advice remains suspect.
Looks like RSW was not involved as Smith & Nephew aquired a US competitor, Blue Belt Technologies, who manufacture robots.
It would seem that using robots for knee surgery has been around since 1985. I think Renishaw surgical robotics are more state of the art precision positioning of surgical tools as opposed to simply supporting a patients leg with a robot during knee surgery.
Received the dividend recently, which for me is the great joy of investing.
I suppose a secondary benefit of owning shares is watching the capital value go up. I see Johnny Renishaw limbering up to get out of the £40-£50 trench and push on to the next one. He has raised his head above the parapet a couple of times and the fire from the selling crowd appears to be pretty intense. It can only be a matter of time though before he goes for it and starts digging into his new position.
Clearly this is a great company. I like how it is run. What worries me is if the current management were to move on, would the money men take over from the engineers, leverage it up and run it into the ground? I suspect that given the chance they would do that in a heartbeat. I just have to hope that others who are holding this share will look to support a continued presence on the board of people who want to engineer things rather than balance sheets.
"Come on Richard. Renishaw's an out-and-out growth stock. You're a value investor. Why are you holding?I often ask myself the same question. Last time I thought about it, I broke out in a cold sweat and offloaded some of the shares. Now ..."
That gives a prospective P/E ratio of 34 or thereabouts, against a market average of something like 20, for what it is worth. Broker earnings estimates have been creeping up lately, though not as much as the price. As we all know, this has always been a thin market with much of the stock tightly held. As people have been pointing out, industrial metrology is starting to look a fashionable business to be in.
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.